Literature DB >> 14506626

Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia.

Graziana Lupattelli1, Simona Marchesi, Rita Lombardini, Donatella Siepi, Francesco Bagaglia, Matteo Pirro, Giovanni Ciuffetti, Giuseppe Schillaci, Elmo Mannarino.   

Abstract

High-density lipoprotein-cholesterol (HDL-c) has a favorable influence on the endothelial function, but the mechanisms of this protective action are not fully understood. We studied lipid parameters, soluble adhesion molecules (vascular cell adhesion molecule-1 [VCAM-1], intercellular adhesion molecule [ICAM-1], E-selectin) oxidized low-density lipoproteins (LDL), and brachial-artery flow-mediated vasodilation (FMV) in 184 hyperlipemic patients (90 men, age 54 +/- 10 years, waist/hip circumference ratio 0.89 +/- 0.07, LDL-cholesterol [LDL-c] 4.9 +/- 1.3 mmol/L, triglycerides 1.8 +/- 0.9 mmol/L, HDL-c 1.3 +/- 0.5 mmol/L) after excluding those with current smoking, diabetes, hypertension, and vascular diseases. Patients were divided into 2 groups on the basis of HDL-c levels: < 1.03 mmol/L (n = 53) v >or= 1.03 mmol/L (n = 131). Patients with low HDL-c showed significantly lower LDL-c (P <.05), higher triglycerides (P <.001), higher body mass index (P <.02), lower FMV (3.7% +/- 2.0% v 4.9% +/- 3.4%, P <.002), higher VCAM-1 (1,195 +/- 395 ng/mL v 984 +/- 303 ng/mL, P <.01), and higher ICAM-1 (406 +/- 78 ng/mL v 364 +/- 68 ng/mL, P <.01). E-selectin and oxidized LDL showed no significant differences. In a multivariate age, oxidized LDL and brachial artery diameter predicted a lower FMV, while HDL-c was an independent predictor of a greater FMV (P =.003). Increasing levels of VCAM-1 and ICAM-1 were predicted by lower HDL-c, while higher oxidized LDL predicted higher VCAM-1 (P <.05). Our data suggest that in hyperlipemic subjects free of cardiovascular disease low HDL-c negatively modulates endothelial function through a lack of oxidation inhibition and a concomitant overexpression of adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506626     DOI: 10.1016/s0026-0495(03)00157-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants.

Authors:  Brian T Steffen; Suzette J Bielinski; Paul A Decker; Cecilia Berardi; Nicholas B Larson; James S Pankow; Erin D Michos; Naomi Q Hanson; David M Herrington; Michael Y Tsai
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

2.  Molecular biology of atherosclerosis.

Authors:  Elmo Mannarino; Matteo Pirro
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

Review 3.  Does nicotinic acid (niacin) lower blood pressure?

Authors:  H E Bays; D J Rader
Journal:  Int J Clin Pract       Date:  2008-11-28       Impact factor: 2.503

Review 4.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

5.  Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia?

Authors:  Maureen E Mays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

Review 6.  Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae?

Authors:  Mohan Satish; Shailendra K Saxena; Devendra K Agrawal
Journal:  J Cardiovasc Transl Res       Date:  2019-03-05       Impact factor: 3.216

7.  Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation.

Authors:  Wan Nor Hanis Wan Ahmad; Farah Sakri; Atiqah Mokhsin; Thuhairah Rahman; Nadzimah Mohd Nasir; Suraya Abdul-Razak; Mazapuspavina Md Yasin; Aletza Mohd Ismail; Zaliha Ismail; Hapizah Nawawi
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

8.  Effect of Low High-Density Lipoprotein Level on Endothelial Activation and Prothrombotic Processes in Coronary Artery Disease-A Pilot Study.

Authors:  Magdalena Lampka; Dorota Olszewska-Słonina; Iga Hołyńska-Iwan; Zofia Grąbczewska; Karolina Obońska; Anna Cwynar; Justyna Stępowska; Karolina Szewczyk-Golec
Journal:  Int J Environ Res Public Health       Date:  2022-07-15       Impact factor: 4.614

Review 9.  Impact of Non-Pharmacological Interventions on the Mechanisms of Atherosclerosis.

Authors:  Daniela Matei; Ioana Buculei; Catalina Luca; Calin-Petru Corciova; Doru Andritoi; Robert Fuior; Daniel-Andrei Iordan; Ilie Onu
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

10.  Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial.

Authors:  Klaus Empen; Robert J A Frost; H Christian Geiss; Carsten Otto; Klaus G Parhofer
Journal:  Cardiovasc Diabetol       Date:  2003-12-08       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.